GlassScriptPhysician profile
Robert James Spicer
NPI 1033313556
$2,012.37
in general payments reported to CMS, 2019-2025
16 companies · $519 in 2025
The $519 reported for 2025 was more than what 79% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $40.92 · 2021: $147 · 2022: $289 · 2023: $445 · 2024: $412 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,376.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,052.86 | 2019-2025 | Wavewriter Alpha Prime 16, Watchman Access System |
| Forte Bio-Pharma LLC | $294.91 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Painteq LLC | $226.55 | 2023-2024 | Painteq |
| Sage Therapeutics, LLC | $102.80 | 2022 | |
| Spinal Simplicity, LLC | $69.94 | 2024-2025 | Ha Minuteman G3-R |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.57 | 2023-2024 | Relistor |
| Fidia Pharma USA INC. | $42.44 | 2024-2025 | Hymovis, Triluron, Hyalgan |
| Pacira Therapeutics, INC. | $40.92 | 2020 | |
| Nevro Corp. | $22.16 | 2024 | Senza |
| Electronic Waveform Lab, INC. | $20.52 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $19.90 | 2025 | |
| Scilex Pharmaceuticals INC. | $19.40 | 2023 | Ztlido |
| Daiichi Sankyo INC. | $13.95 | 2019 | |
| Abbott Laboratories | $13.33 | 2019 | |
| Eisai INC. | $12.89 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Spicer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.